Key result
Recombinant Poliovirus 2A protease was successfully expressed in BL21 (DE3) pLysS cells, purified, and its 3D structure modeled to highlight potential targets for antiviral drug development.
Why the study?
Poliovirus 2A protease plays a vital role in viral replication and down-regulation of host cell protein synthesis, prompting further characterization of the protein.
Characterization and 3D modeling of Poliovirus 2A protease provides structural insights that could aid in antiviral drug development.
Structural modeling identifies poliovirus 2A targets; leaves open antiviral translation to clinical use.
Poliovirus 2A protease (PV2Apro) plays a vital role in viral replication and down-regulation of host cell protein synthesis. In order to understand more concerning PV2Apro, the protein was over-expressed in bacteria following amplification using sense and antisense primers and cloning in pET15b. Several expression hosts were tested and BL21 (DE3) pLysS cells gave the best expression of PV2Apro with minimal unwanted protein expression following IPTG induction. The 2Apro protein was purified to homogeneity using column chromatography, its solubility determined and its molecular weight and composition determined by MALDI-TOF mass spectrometry. The protease was found in the insoluble fraction and the purified protein had a slightly lower molecular weight than predicted. Moreover, three dimensional structure was modelled using template 1z8r with 58% identity and validated using ramachandran plot. Results revealed that most of the residues lie in favoured and allowed regions. These findings could help in a better understanding of PV2Apro structure and inhibition thus, highlighting potential targets for antiviral drug development.
No takes yet. Share an insight, caveat, or question.
Younus et al. (2018) studied Poliovirus. Recombinant Poliovirus 2A Protease (PV2Apro) expression and purification was evaluated on Protein expression, purification, and structural modeling. Recombinant Poliovirus 2A protease was successfully expressed in BL21 (DE3) pLysS cells, purified, and its 3D structure modeled to highlight potential targets for antiviral drug development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: